Target intelligence / Profile preview

Expanded CTG repeat RNA foci

Molecular classification
Other (pathological RNA aggregate), RNA structural element, Aberrant secondary structure (hairpins/stem loops)
01

Overview

Expanded CTG repeat RNA foci are abnormal nuclear aggregates formed by RNAs containing excessive CTG repeats, as seen especially in myotonic dystrophy type 1. These foci arise due to the ability of long CTG repeat tracts to fold into stable hairpin structures, recruiting various RNA-binding proteins (notably MBNL1, MBNL2, and others) and sequestering them in the nucleus. This sequestration alters normal RNA splicing, retention, and metabolism, initiating a toxic gain-of-function effect. Clinically, such foci underpin multisystem pathology in DM1 and other repeat expansion diseases. Therapeutic strategies aim to dissolve these foci or prevent their formation, including novel small molecules, antisense RNAs, and genome editing approaches.

Other names
Expanded CUG repeat RNA fociCUG RNA nuclear fociNuclear RNA fociRibonuclear inclusionsCTG repeat RNA aggregates
02

Mechanism of action

Disruption or dissolution of RNA foci (by blocking secondary structure formation or repeat RNA-protein interactions); inhibition of toxic gain-of-function by reducing protein sequestration; genome editing to reduce CTG repeat length

03

Biological functions

Sequestration of RNA-binding proteins (RBPs)Dysregulation of alternative splicingNuclear retention of expanded RNAsPromotion of pathological RNA–protein interactionsInduction of cell stress
04

Disease associations

Neurodegenerative diseaseMuscle disease (myotonic dystrophy type 1)Other repeat expansion disorders (e.g., fragile X-associated tremor/ataxia syndrome, some forms of ALS)
05

Safety considerations

Off-target effects of genome editingNon-specific disruption of physiological RNA-protein interactionsPossible toxicity from complete dissolution of all nuclear foci (some may be part of normal physiology)Delivery and specificity challenges for oligonucleotide therapies
06

Interacting drugs

Cyclic pyrrole-imidazole polyamides (e.g. CWG-cPIP)

3 more in the full profile.

07

Biomarkers

Presence and abundance of nuclear RNA foci (usually visualized by FISH in patient cells)MBNL protein aggregation in fociAlternative splicing dysregulation in target genes

Beyond the preview

Go deeper on Expanded CTG repeat RNA foci.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Expanded CTG repeat RNA foci.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call